Core Viewpoint - On January 29, *ST Kaixin executed a block trade of 220,000 shares, amounting to 6.875 million yuan, which represented 14.75% of the total trading volume for the day, with a transaction price of 31.25 yuan, reflecting a discount of 4.78% compared to the market closing price of 32.82 yuan [1]. Group 1 - The block trade involved a total of 220,000 shares at a price of 31.25 yuan per share [1]. - The total transaction value for the block trade was 6.875 million yuan [1]. - The transaction price was 4.78% lower than the market closing price of 32.82 yuan [1]. Group 2 - The block trade was executed by two brokerage firms: Zhongtai Securities and Guojin Securities, with the selling party being Guolian Minsheng Securities [2]. - The trading volume included 100,000 shares from Zhongtai Securities and 120,000 shares from Guojin Securities [2].

Core Viewpoint - *ST Kaixin (300899.SZ) is forecasting significant revenue and profit growth for the year 2025, transitioning from a loss in the previous year to profitability in the upcoming year [1] Financial Performance Summary - The company expects operating revenue for 2025 to be between 194 million and 230 million yuan, compared to 81.61 million yuan in the same period last year, indicating a year-on-year increase of 137.73% [1] - The net profit attributable to shareholders is projected to be between 26 million and 33 million yuan, a turnaround from a loss of 1.65 million yuan in the previous year [1] - The net profit after deducting non-recurring gains and losses is anticipated to be between 23 million and 30 million yuan, compared to a loss of 11.45 million yuan in the prior year [1] Growth Drivers - The primary reasons for the expected performance improvement include a low revenue base in 2024 and favorable order completion conditions in 2025, which are contributing to the anticipated growth in performance [1]

公司于近日收到张蔚出具的《关于股份减持计划实施完成的告知函》。张蔚 已于上述减持计划期间通过集中竞价方式合计减持 137,997 股，占公司总股本的 0.2164%，减持计划实施完成。具体情况如下： 一、股东减持计划实施情况 1、减持股份来源：通过非交易过户取得的首次公开发行前上海璨冉企业管 理咨询合伙企业（有限合伙）持有上海凯鑫的股份（具体内容详见公司于 2022 年 1 月 27 日在巨潮资讯网（http://www.cninfo.com.cn）刊登的《关于股东完成证 券非交易过户的公告》）。 | 股东名称 | 减持方式 | | 减持期间 | | | 减持均价 （元/股） | 减持股数 （股） | 减持比例 （%） | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 张蔚 | 集中竞价 | 2025 2026 | 年 11 11 年 1 | 月 月 26 | 日至 日 | 30.98-37.58 | 137,997 | 0.2164 | | 合计 | - | | - | | | - | 137,997 | 0.2164 | 证券代码：30 ...

证券代码：300899 证券简称：*ST凯鑫 公告编号：2026-005 上海凯鑫分离技术股份有限公司 关于首发前员工持股平台减持股份的预披露公告 （二）股东持股情况如下： | 姓名 | 持股数量（股） | 占总股本的比例（%） | | --- | --- | --- | | 上海济谦投资管理合伙 | 1,502,564 | 2.36 | | 企业（有限合伙） | | | 二、本次减持计划的主要内容 首发前员工持股平台上海济谦投资管理合伙企业（有限合伙）保证向本公司 提供的信息披露内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 截至本公告披露日，首发前员工持股平台上海济谦投资管理合伙企业（有限 合伙）（以下简称"上海济谦"）持有上海凯鑫分离技术股份有限公司（以下简 称"公司"或"上海凯鑫"）股份 1,502,564 股（占公司总股本 2.36%），拟在本减持 计划披露之日起 15 个交易日后的 3 个月内（即 2026 年 2 月 27 日至 2026 年 5 月 26 日），以集中竞价方式合计减持本公司股份不超过 5 ...

Financial Performance Expectations - The company expects a net profit of between 26 million and 33 million CNY for the fiscal year 2025, marking a turnaround from a loss of 1.6462 million CNY in the same period last year, representing a growth of 1,679.39%[3] - Total revenue is projected to be between 194 million and 230 million CNY, a significant increase of 137.73% compared to 81.61 million CNY in the previous year[5] - The profit before tax is expected to be between 28 million and 35 million CNY, compared to a loss of 4.4453 million CNY in the previous year, indicating a growth of 729.88%[3] - The net profit after deducting non-recurring gains and losses is anticipated to be between 23 million and 30 million CNY, a growth of 300.93% from a loss of 11.4465 million CNY last year[3] Asset Projections - The company's total assets attributable to shareholders are projected to be between 635 million and 643 million CNY at the end of the fiscal year[3] Factors Influencing Performance - The significant performance improvement is attributed to a low revenue base in 2024 and strong order fulfillment in 2025[6] Financial Risks and Warnings - The company’s stock has been under financial delisting risk warning since April 30, 2025, due to previous negative net profit and revenue below 100 million CNY[7] - The specific financial data for the fiscal year 2025 will be detailed in the annual report, urging investors to make cautious decisions[7]

证券代码：300899 证券简称：*ST凯鑫 公告编号：2026-004 上海凯鑫分离技术股份有限公司 关于公司股票可能被终止上市的风险提示公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、上海凯鑫分离技术股份有限公司（以下简称"公司"）于 2025 年 4 月 29 日披露了《关于公司股票交易被实施退市风险警示暨停复牌的公告》（公告 编号：2025-022），因公司 2024 年度经审计的利润总额、净利润、扣除非经常 性损益后的净利润为负值，且扣除后营业收入低于 1 亿元，根据《深圳证券交易 所创业板股票上市规则》第 10.3.1 条第（一）项相关规定，公司股票自 2025 年 4 月 30 日起被实施退市风险警示。若公司出现《深圳证券交易所创业板股票上 市规则》第 10.3.11 条规定的情形，公司股票存在被终止上市的风险。 （二）经审计的期末净资产为负值。 （三）财务会计报告被出具保留意见、无法表示意见或者否定意见的审计报 告。 2、《深圳证券交易所创业板股票上市规则》第 10.3.5 条规定："上市公司 因触及第 10.3.1 条第 ...

证券代码：300899 证券简称：*ST凯鑫 公告编号：2026-002 上海凯鑫分离技术股份有限公司 关于确认联营公司长期股权投资亏损的提示性公告 符合《企业会计准则》和公司相关会计政策，依据充分，体现了会计谨慎性原则， 符合公司实际情况。本次确认投资亏损后能更加公允的反映公司财务状况、资产 价值及经营成果。 四、风险提示 1、本公告中列示的所有数据均未经审计。 2、公司指定的信息披露媒体为巨潮资讯网（http://www.cninfo.com.cn）及《证 券时报》、《上海证券报》，公司所有信息均以在上述符合中国证监会规定条件的 媒体刊登的信息为准。敬请广大投资者理性投资，注意投资风险。 一、重要提示 上海凯鑫分离技术股份有限公司（以下简称"上海凯鑫"或"公司"）持有宜宾 雅泰生物科技有限公司（以下简称"雅泰"）16.75%股份，上市公司不拥有控制权， 本次确认长期股权投资的投资亏损不对上市公司正常经营产生重大影响。 二、长期股权投资账面情况 2025 年年初，公司持有雅泰的长期股权投资期初余额为 12,985,448.85 元。 2025 年末公司收到雅泰管理层通知，雅泰经营环境发生重大变化，公司管理层 ...

Core Viewpoint - The company, *ST Kaixin, is actively expanding its presence in international markets, particularly in Southeast Asia, Africa, and South Asia, while also exploring opportunities in the European Union market [1]. Group 1 - The company has entered multiple countries and regions, including Malaysia, Ethiopia, and Pakistan, to address the growing demand for industrial wastewater treatment [1]. - As a provider of integrated solutions for membrane separation technology, the company offers a comprehensive package that includes materials, equipment, and processes, which is particularly suited for clients with high technical requirements [1]. - The company's innovative technology and tailored solutions have gained recognition from international clients, indicating a positive reception in the global market [1].

证券代码：300899 证券简称：*ST凯鑫 公告编号：2025-050 上海凯鑫分离技术股份有限公司 关于控股股东、实际控制人及其他股东协议转让事宜 记前涉及的前期价款支付；根据《股份转让协议》约定，受让方需在过户登记后 完成剩余股份转让价款的支付。 注：以上比例合计数与各明细数相加之和在尾数上如有差异，系四舍五入所致。 完成过户登记暨股东权益变动的进展公告 控股股东葛文越、实际控制人葛文越、邵蔚、刘峰、杨旗、杨昊鹏保证向本 公司提供的信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本次协议转让的基本情况 公司实际控制人葛文越、邵蔚、刘峰、杨旗、杨昊鹏及持股 5%以上股东申 雅维（"转让方"）与吉学文于 2025 年 11 月 10 日签署了《股份转让协议》，约定 将其合计持有的公司 3,189,174 股无限售条件流通股股份（占公司总股本的 5.00%），以人民币 27.85 元/股的价格，通过协议转让的方式转让给吉学文，股 份转让价款共计人民币 88,818,496.00 元。具 ...

Core Viewpoint - The A-share market shows a mixed performance with a slight increase in the Shanghai Composite Index, while several stocks are experiencing a death cross between their 5-day and 10-day moving averages, indicating potential bearish trends [1] Group 1: Market Overview - As of 10:30 AM, the Shanghai Composite Index is at 3921.77 points, with a change of 0.49% [1] - The total trading volume of A-shares today is 981.369 billion yuan [1] Group 2: Stocks with Death Cross - A total of 315 A-shares have seen their 5-day moving averages cross below their 10-day moving averages [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - China Merchants Energy (招商轮船) with a distance of -2.04% [1] - Chlor-alkali Chemical (氯碱化工) at -1.69% [1] - Tianci Materials (天赐材料) at -1.47% [1] Group 3: Individual Stock Performance - China Merchants Energy (601872) is down 1.20% with a latest price of 8.22 yuan, which is 6.01% below its 10-day moving average [1] - Chlor-alkali Chemical (600618) has decreased by 2.61%, with a latest price of 12.29 yuan, 4.09% below its 10-day moving average [1] - Tianci Materials (002709) increased by 1.74%, with a latest price of 39.26 yuan, 2.37% below its 10-day moving average [1]